Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Gabriella d'Ettorre and Francesco Pugliese.
Gabriella d'Ettorre
Connection Strength
2.228
Francesco Pugliese
  1. Oxygen Sparing Effect of Bacteriotherapy in COVID-19. Nutrients. 2021 Aug 23; 13(8).
    View in: PubMed
    Score: 0.241
  2. Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study. Front Nutr. 2020; 7:613928.
    View in: PubMed
    Score: 0.231
  3. Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report. Thromb Haemost. 2021 01; 121(1):102-105.
    View in: PubMed
    Score: 0.230
  4. Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial. J Med Virol. 2021 04; 93(4):2210-2220.
    View in: PubMed
    Score: 0.228
  5. Probiotics and COVID-19. Lancet Gastroenterol Hepatol. 2020 08; 5(8):721-722.
    View in: PubMed
    Score: 0.224
  6. Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. Front Med (Lausanne). 2020; 7:389.
    View in: PubMed
    Score: 0.223
  7. Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review. Nutrients. 2020 Jun 08; 12(6).
    View in: PubMed
    Score: 0.222
  8. Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality. Intern Emerg Med. 2021 08; 16(5):1231-1237.
    View in: PubMed
    Score: 0.060
  9. Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up. Int J Cardiol. 2021 09 15; 339:235-242.
    View in: PubMed
    Score: 0.060
  10. Comparison Between Hospitalized Patients Affected or Not Affected by Coronavirus Disease 2019. Clin Infect Dis. 2021 06 15; 72(12):e1158-e1159.
    View in: PubMed
    Score: 0.059
  11. The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study). J Med Virol. 2021 Jul; 93(7):4319-4325.
    View in: PubMed
    Score: 0.059
  12. Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19). Virus Res. 2021 04 02; 295:198283.
    View in: PubMed
    Score: 0.058
  13. Retinal involvement and ocular findings in COVID-19 pneumonia patients. Sci Rep. 2020 10 15; 10(1):17419.
    View in: PubMed
    Score: 0.057
  14. Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. Eur J Clin Invest. 2021 Jan; 51(1):e13418.
    View in: PubMed
    Score: 0.057
  15. Nox2 activation in Covid-19. Redox Biol. 2020 09; 36:101655.
    View in: PubMed
    Score: 0.056
  16. Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19. Circ Res. 2020 07 17; 127(3):400-401.
    View in: PubMed
    Score: 0.055
  17. Is teicoplanin a complementary treatment option for COVID-19? The question remains. Int J Antimicrob Agents. 2020 Aug; 56(2):106029.
    View in: PubMed
    Score: 0.055
  18. Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients. J Clin Virol. 2020 07; 128:104450.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.